Re:Scientists discover a highly potent antibody against SARS...
by johncolanduoni on Thursday October 14, 2021 @02:38PM
(#28868163)
> The technology to make monoclonal antibodies is simpler than that for mRNA vaccines.
It’s more mature technology, but unlike the mRNA vaccines it’s not cell free and as a result is harder to scale up. At similar scale mRNA will still be cheaper; that’s one if mRNA’s biggest selling points.
Re:Scientists discover a highly potent antibody against SARS...
by vajrabum on Wednesday October 13, 2021 @05:12PM
(#28857795)
You need about 30 ug of MRNA vaccine. For Regeneron the dosage is an initial dose of 600 mg followed by 300 mg every other week. Pfizer is $19.50/dose. Moderna is $15/dose. Regeneron is $2100/dose. And that's with the US govt having bought millions of doses of Regeneron.
The technology to make monoclonal antibodies is simpler than that for mRNA vaccines.
> That's also the reason they tend to be so expensive
Economies of scale play a big role. At similar scale mab should be cheaper than mRNA.